查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1487688

大麻二酚 (CBD) 油市场 - 按来源（大麻、大麻）、产品类型（原味、混合）、产品类别（调味、原味）、应用（保健品、药品）、配方、配销通路、全球预测2024 - 2032

Cannabidiol (CBD) Oil Market - By Source (Hemp, Marijuana), Product Type (Original, Blended), Product Category (Flavoured, Unflavoured), Application (Nutraceuticals, Pharmaceuticals), Formulation, Distribution Channel, Global Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 225 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在专注于发现其潜在优势的研发工作不断增加的推动下，2024 年至 2032 年间，全球大麻二酚 (CBD) 油市场规模的复合年增长率将达到 18.6%。随着科学研究不断揭示 CBD 的治疗特性，包括其减轻疼痛、减少焦虑和减轻各种医疗状况症状的潜力，消费者对 CBD 产品的兴趣呈指数级增长。

例如，2024 年 2 月，科罗拉多大学博尔德分校的新研究表明，富含 CBD 的大麻产品可能比以 THC 为主的大麻产品更有效地减少焦虑，并且没有潜在的副作用。这项研究发表在《大麻与大麻素研究》上，涉及 300 名参与者，是第一个探讨合法大麻对焦虑症状影响的随机试验。

此外，各地区的监管变化和大麻衍生产品日益合法化也有助于市场的扩张。随着消费者寻求自然疗法和传统药物的替代品，CBD油成为有前途的选择。这种不断增长的需求凸显了向整体健康实践的典范转移，并推动了 CBD 产业的创新，推动其成长轨迹。

整个大麻二酚 (CBD) 油产业根据来源、产品类型、产品类别、应用、配方、配销通路和地区进行分类。

大麻细分市场将在 2024 年至 2032 年间经历突破性发展。随着全球对大麻态度的转变和合法化努力的进展， CBD 油的市场不断扩大。消费者寻求治疗各种疾病的自然疗法，导致对 CBD 产品的需求不断增长。此外，萃取技术和产品配方的进步增强了 CBD 油的吸引力，推动其在更广泛的大麻产业中的市场成长。

从2024 年到2032 年，混合细分市场的大麻二酚(CBD) 油市场份额将实现显着的复合年增长率。 ，满足不同消费者的喜好和需求。无论是与精油结合以获得芳香疗法的功效，还是注入维生素和营养素以增加健康益处，混合 CBD 油产品都提供了全面的健康方法。这些混合物为消费者提供了方便且可客製化的解决方案，以解决从缓解压力到皮肤护理等各种健康问题。随着市场不断创新和多元化，对混合 CBD 油产品的需求可能会成长，从而塑造产业成长前景。

欧洲大麻二酚 (CBD) 石油市场从 2024 年到 2032 年将呈现可观的复合年增长率。欧洲消费者越来越多地寻求自然疗法来解决各种健康问题，推动了对 CBD 油产品的需求。此外，健康和护肤行业正在接受 CBD 油，因为它具有所谓的好处，进一步推动了市场成长。随着可近性的不断提高和产品种类的广泛（包括油、胶囊和外用药），欧洲对 CBD 油的需求可能会继续呈上升趋势。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • CBD 不断增长的医疗应用
      • 与传统药物相比，人们对 CBD 的偏好越来越高
      • CBD 产品核准的监管环境不断变化
      • 零售店 CBD 产品的销售增加
    • 产业陷阱与挑战
      • 与 CBD 油相关的副作用
      • 市面上有假冒和合成产品
      • 监理不确定性
  • 成长潜力分析
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪錶板

第 5 章：市场估计与预测：按来源划分，2018 年 - 2032 年

  • 主要趋势
  • 麻
  • 大麻

第 6 章：市场估计与预测：按产品类型，2018 年 - 2032 年

  • 主要趋势
  • 原来的
  • 混合

第 7 章：市场估计与预测：按产品类别，2018 - 2032

  • 主要趋势
  • 调味 CBD 油
  • 无味 CBD 油

第 8 章：市场估计与预测：按应用划分，2018 年 - 2032 年

  • 主要趋势
  • 营养保健品
  • 药品
    • 疼痛管理
    • 焦虑和抑郁
    • 睡眠障碍
    • 皮肤护理
    • 神经系统疾病
    • 其他製药应用

第 9 章：市场估计与预测：按配方划分，2018 年 - 2032 年

  • 主要趋势
  • 药丸和胶囊
  • 乳霜和走珠
  • 透皮贴剂
  • 滴
  • 其他配方

第 10 章：市场估计与预测：按配销通路，2018 年 - 2032 年

  • 主要趋势
  • 在线的
  • 离线
    • 医院药房
    • 零售店

第 11 章：市场估计与预测：按地区划分，2018 年 - 2032 年

  • 主要动向：按地区
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 中东和非洲其他地区

第 12 章：公司简介

  • Aurora Cannabis Inc
  • Bluebird Botanicals
  • BIOTA Biosciences
  • CHARLOTTE'S WEB
  • Elixinol
  • Endoca
  • Evora Worldwide
  • Green Roads
  • Hempstrol
  • Health Horizons
  • Medical Mary, LLC
  • Medterra CBD
  • Neurogan
简介目录
Product Code: 8545

Global Cannabidiol (CBD) Oil Market Size will witness 18.6% CAGR between 2024 and 2032, driven by increasing research and development efforts focused on uncovering its potential benefits. As scientific studies continue to shed light on CBD's therapeutic properties, including its potential to alleviate pain, reduce anxiety, and mitigate symptoms of various medical conditions, consumer interest in CBD products is growing exponentially.

For instance, in February 2024, new research from CU Boulder suggested that cannabis products high in CBD may be more effective at reducing anxiety than those dominated by THC and without the potential side effects. Published in Cannabis and Cannabinoid Research, the study involving 300 participants was the first randomized trial to explore the impact of legally available cannabis on anxiety symptoms.

Moreover, regulatory changes and increasing legalization of cannabis-derived products in various regions contribute to the market's expansion. As consumers seek natural remedies and alternatives to traditional pharmaceuticals, CBD oil emerges as a promising option. This rising demand underscores a paradigm shift towards holistic wellness practices and fuels innovation in the CBD industry, propelling its growth trajectory.

The overall Cannabidiol (CBD) Oil Industry is classified based on the source, product type, product category, application, formulation, distribution channel, and region.

The marijuana segment will undergo groundbreaking development from 2024 to 2032. Derived from the cannabis plant, CBD oil has gained popularity for its potential therapeutic benefits without the psychoactive effects of THC, another compound found in marijuana. As attitudes towards marijuana shift and legalization efforts progress globally, the market for CBD oil expands. Consumers seek natural remedies for various ailments, contributing to the growing demand for CBD products. Additionally, advancements in extraction techniques and product formulations enhance the appeal of CBD oil, driving its market growth within the broader marijuana industry.

The cannabidiol (CBD) oil market share from the blended segment will register a noteworthy CAGR from 2024 to 2032. Blending CBD oil with other natural compounds or ingredients enhances its versatility and effectiveness, catering to diverse consumer preferences and needs. Whether combined with essential oils for aromatherapy benefits or infused with vitamins and nutrients for added health benefits, blended CBD oil products offer a holistic approach to wellness. These blends provide consumers with a convenient and customizable solution to address various health concerns, from stress relief to skin care. As the market continues to innovate and diversify, the demand for blended CBD oil products could grow, shaping the industry growth outlook.

Europe cannabidiol (CBD) oil market will showcase an appreciable CAGR from 2024 to 2032. As regulatory frameworks evolve and public perception towards cannabis-derived products shifts, the market for CBD oil expands rapidly. Consumers in Europe are increasingly seeking natural remedies for various health concerns, driving the demand for CBD oil products. Moreover, the wellness and skincare industries are embracing CBD oil for its purported benefits, further fueling market growth. With increasing accessibility and a wide range of product offerings, including oils, capsules, and topicals, the demand for CBD oil in Europe could continue its upward trajectory.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing medical applications of CBD
      • 3.2.1.2 Growing preference for CBD over conventional pharmaceuticals
      • 3.2.1.3 Changing regulatory landscape for approval of CBD products
      • 3.2.1.4 Increasing sales of CBD products in retail stores
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Side effects associated with CBD oil
      • 3.2.2.2 Counterfeit and synthetic products available in the market
      • 3.2.2.3 Regulatory uncertainties
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
    • 3.5.1 Supplier power
    • 3.5.2 Buyer power
    • 3.5.3 Threat of new entrants
    • 3.5.4 Threat of substitutes
    • 3.5.5 Industry rivalry
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Source, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hemp
  • 5.3 Marijuana

Chapter 6 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Original
  • 6.3 Blended

Chapter 7 Market Estimates and Forecast, By Product Category, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Flavoured CBD oil
  • 7.3 Unflavoured CBD oil

Chapter 8 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Nutraceuticals
  • 8.3 Pharmaceuticals
    • 8.3.1 Pain management
    • 8.3.2 Anxiety and depression
    • 8.3.3 Sleep disorder
    • 8.3.4 Skin care
    • 8.3.5 Neurological disorders
    • 8.3.6 Other pharmaceutical applications

Chapter 9 Market Estimates and Forecast, By Formulation, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Pills & capsules
  • 9.3 Creams & roll-ons
  • 9.4 Transdermal patches
  • 9.5 Drops
  • 9.6 Other formulations

Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Million)

  • 10.1 Key trends
  • 10.2 Online
  • 10.3 Offline
    • 10.3.1 Hospital pharmacy
    • 10.3.2 Retail stores

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 11.1 Key trends, by region
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Rest of Latin America
  • 11.6 Middle East and Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 Aurora Cannabis Inc
  • 12.2 Bluebird Botanicals
  • 12.3 BIOTA Biosciences
  • 12.4 CHARLOTTE'S WEB
  • 12.5 Elixinol
  • 12.6 Endoca
  • 12.7 Evora Worldwide
  • 12.8 Green Roads
  • 12.9 Hempstrol
  • 12.10 Health Horizons
  • 12.11 Medical Mary, LLC
  • 12.12 Medterra CBD
  • 12.13 Neurogan